Calculous pyelonephritis.
Koga S, Arakaki Y, Matsuoka M, Ohyama C.
Int Urol Nephrol. 1992;24(2):109-12. doi: 10.1007/BF02549636.
Renal pseudoaneurysm after calculous pyelonephritis.
Koyama Y, Yumioka T, Ohno H.
IJU Case Rep. 2024 Feb 27;7(3):234-237. doi: 10.1002/iju5.12711. eCollection 2024 May.
[CALCULOUS PYELONEPHRITIS].
POGORELKO IP, VOINO-IASENETSKII AM.
Klin Med (Mosk). 1964 Aug;42:16-23.
[Clinical features and the process of renal stone formation in elderly patients with calculous pyelonephritis].
Fujita J, Kami W, Baba M, Chinen T.
Nihon Ronen Igakkai Zasshi. 2024;61(4):472-479. doi: 10.3143/geriatrics.61.472.
[The immune status of patients with chronic calculous pyelonephritis and the possibilities for the correction of its disorders].
Lozinskiĭ MV, Zemskov AM, Chernov IuN.
Urol Nefrol (Mosk). 1991 May-Jun;(3):70-5.
Can excretory phase computed tomography predict bacteremia in obstructive calculous pyelonephritis?
Yagihashi Y, Shimabukuro S, Toyosato T, Arakaki Y.
Int Urol Nephrol. 2018 Dec;50(12):2123-2129. doi: 10.1007/s11255-018-1999-2. Epub 2018 Oct 13.
Xanthogranulomatous pyelonephritis: a reappraisal.
Grainger RG, Longstaff AJ, Parsons MA.
Lancet. 1982 Jun 19;1(8286):1398-401. doi: 10.1016/s0140-6736(82)92511-9.
[Complex therapy and prevention of exacerbations of calculous pyelo- nephritis].
Derevyanko TI, Pridchin SV, Ryzhkova EV.
Urologiia. 2023 May;(2):111-114.
[Characteristics of the pathogenic potential of Escherichia coli isolated from patients with calculous pyelonephritis].
Pashkova TM, Morozova NV, Kuzmin MD, O KL, Popova LP.
Urologiia. 2021 Sep;(4):19-24.
Impacts of clinical backgrounds and intervention strategies on duration of intravenous antibiotics treatments in patients diagnosed with calculous pyelonephritis: A single-center retrospective study.
Baba K, Ito K, Oki R, Furuya Y, Magari T, Ogura H, Kurosawa I.
J Infect Chemother. 2025 Feb;31(2):102559. doi: 10.1016/j.jiac.2024.11.009. Epub 2024 Nov 13.
